Navigating ferroptosis via an NADPH sensor

Chao Mao,Boyi Gan

DOI: https://doi.org/10.1038/s41556-022-00963-3

IF: 21.3

2022-08-09

Nature Cell Biology

Abstract:NADPH levels serve as a biomarker of sensitivity to ferroptosis, but the regulators that detect cellular NADPH levels and modulate downstream ferroptosis responses are unknown. A study now identifies MARCHF6 in the ubiquitin system as an NADPH sensor that suppresses ferroptosis.

cell biology

What problem does this paper attempt to address?

An NADPH sensor that regulates cell ferroptosis

Guixing Kuang,Weidong Wang,Dan Xiong,Chong Zeng

DOI: https://doi.org/10.1186/s12967-022-03658-3

IF: 8.44

2022-10-21

Journal of Translational Medicine

Abstract:Ferroptosis is a new form of programmed cell death, which achieved great breakthroughs in cell biology during past decade. However, the regulation of ferroptosis is yet to be identified thoroughly. The latest study published on Nature cell biology by Nguyen and colleagues found a new NADPH sensor, MARCHF6 an E3 ubiquitin ligase, mediates ferroptosis in tumor growth and animal development. This finding provides a novel insight into ubiquitin system and energy metabolism in regulation of ferroptosis, which may open up new avenues for tumor treatment.

medicine, research & experimental
The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis

Kha The Nguyen,Sang-Hyeon Mun,Jihye Yang,Jongeun Lee,Ok-Hee Seok,Eunjeong Kim,Dasom Kim,So Young An,Dong-Young Seo,Jeong-Yong Suh,Yoontae Lee,Cheol-Sang Hwang

DOI: https://doi.org/10.1038/s41556-022-00973-1

IF: 21.3

2022-08-09

Nature Cell Biology

Abstract:Ferroptosis is a unique form of cell death caused by excessive iron-dependent lipid peroxidation. The level of the anabolic reductant NADPH is a biomarker of ferroptosis sensitivity. However, specific regulators that detect cellular NADPH levels, thereby modulating downstream ferroptosis cascades, are largely unknown. We show here that the transmembrane endoplasmic reticulum MARCHF6 E3 ubiquitin ligase recognizes NADPH through its C-terminal regulatory region. This interaction upregulates the E3 ligase activity of MARCHF6, thus downregulating ferroptosis. We also found that MARCHF6 mediates the degradation of the key ferroptosis effectors ACSL4 and p53. Furthermore, inhibiting ferroptosis rescued the growth of MARCHF6-deficient tumours and peri-natal lethality of Marchf6 –/– mice. Together, these findings identify MARCHF6 as a previously unknown NADPH sensor in the ubiquitin system and a crucial regulator of ferroptosis.

cell biology
Targeting Ferroptosis in Breast Cancer

Zhaoqing Li,Feng Cao,Cong Chen,Yulu Zhou,Dongyan Hu,Jingjing Yang,Yongxia Chen,Wenying Zhuo,Misha Mao,Xun Zhang,Ling Xu,Linbo Wang,Jichun Zhou

DOI: https://doi.org/10.1186/s40364-020-00230-3

2020-01-01

Biomarker Research

Abstract:Ferroptosis is a recently discovered distinct type of regulated cell death caused by the accumulation of lipid-based ROS. Metabolism and expression of specific genes affect the occurrence of ferroptosis, making it a promising therapeutic target to manage cancer. Here, we describe the current status of ferroptosis studies in breast cancer and trace the key regulators of ferroptosis back to previous studies. We also compare ferroptosis to common regulated cell death patterns and discuss the sensitivity to ferroptosis in different subtypes of breast cancer. We propose that viewing ferroptosis-related studies from a historical angle will accelerate the development of ferroptosis-based biomarkers and therapeutic strategies in breast cancer.
Regulation of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis inhibition

Na Liu,Wei-Long Wu,Xiao-Rui Wan,Jing Wang,Jia-Ni Huang,Yi-Yue Jiang,Yi-Chao Sheng,Jun-Chao Wu,Zhong-Qin Liang,Zheng-Hong Qin,Yan Wang

DOI: https://doi.org/10.1016/j.redox.2024.103176

Abstract:Excitotoxicity is a prevalent pathological event in neurodegenerative diseases. The involvement of ferroptosis in the pathogenesis of excitotoxicity remains elusive. Transcriptome analysis has revealed that cytoplasmic reduced nicotinamide adenine dinucleotide phosphate (NADPH) levels are associated with susceptibility to ferroptosis-inducing compounds. Here we show that exogenous NADPH, besides being reductant, interacts with N-myristoyltransferase 2 (NMT2) and upregulates the N-myristoylated ferroptosis suppressor protein 1 (FSP1). NADPH increases membrane-localized FSP1 and strengthens resistance to ferroptosis. Arg-291 of NMT2 is critical for the NADPH-NMT2-FSP1 axis-mediated suppression of ferroptosis. This study suggests that NMT2 plays a pivotal role by bridging NADPH levels and neuronal susceptibility to ferroptosis. We propose a mechanism by which the NADPH regulates N-myristoylation, which has important implications for ferroptosis and disease treatment.
Ferroptosis Regulation by Nutrient Signalling

Yingao Qi,Xiaoli Zhang,Zhihui Wu,Min Tian,Fang Chen,Wutai Guan,Shihai Zhang

DOI: https://doi.org/10.1017/s0954422421000226

2021-01-01

Nutrition Research Reviews

Abstract:Tremendous progress has been made in the field of ferroptosis since this regulated cell death process was first named in 2012. Ferroptosis is initiated upon redox imbalance and driven by excessive phospholipid peroxidation. Levels of multiple intracellular nutrients (iron, selenium, vitamin E and coenzyme Q10) are intimately related to the cellular antioxidant system and participate in the regulation of ferroptosis. Dietary intake of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) regulates ferroptosis by directly modifying the fatty acid composition in cell membranes. In addition, amino acids and glucose (energy stress) manipulate the ferroptosis pathway through the nutrient-sensitive kinases mechanistic target of rapamycin complex 1 (mTORC1) and AMP-activated protein kinase (AMPK). Understanding the molecular interaction between nutrient signals and ferroptosis sensors might help in the identification of the roles of ferroptosis in normal physiology and in the development of novel pharmacological targets for the treatment of ferroptosis-related diseases.
The role of non-coding RNAs in ferroptosis regulation

Ran Qi,Yixuan Bai,Yuhua Wei,Nanbin Liu,Baomin Shi

DOI: https://doi.org/10.1016/j.jtemb.2021.126911

IF: 3.995

2022-01-01

Journal of Trace Elements in Medicine and Biology

Abstract:Ferroptosis is a newly recognized form of cell death that is distinct from apoptosis, necrosis, autophagy in morphology, biochemistry, and heredity. The basic process of ferroptosis involves disordered permeability of plasma membrane, which is caused by abnormal accumulation of lipids and reactive oxygen species (ROS). The regulatory mechanism of ferroptosis is important due to its involvement in tumor progression, neurotoxicity, neurodegenerative diseases, acute renal failure, and ischemia-reperfusion injury. Recent studies have shown that in ferroptosis metabolism, non-coding RNAs (ncRNAs) can interfere with multiple signaling pathways at both the pre-transcriptional and post-transcriptional levels. Despite great progress, current research on the mechanism of ncRNAs and ferroptosis remains insufficient. This review provides an overview of the main mechanisms and targets of ferroptosis and focuses on the mechanisms of non-coding RNA regulation. Analyzing the deficiencies in current research may provide ideas for future studies to investigate.
FSP1 oxidizes NADPH to suppress ferroptosis

Sitao Zhang,Shengsong Gou,Qian Zhang,Xin Yong,Boyi Gan,Da Jia

DOI: https://doi.org/10.1038/s41422-023-00879-z

IF: 44.1

2023-09-23

Cell Research

Abstract:Cell Research, Published online: 22 September 2023; doi:10.1038/s41422-023-00879-z FSP1 oxidizes NADPH to suppress ferroptosis

cell biology
Context-dependent regulation of ferroptosis sensitivity

Leslie Magtanong,Grace D Mueller,Kevin J Williams,Maximilian Billmann,Katherine Chan,David A Armenta,Lauren E Pope,Jason Moffat,Charles Boone,Chad L Myers,James A Olzmann,Steven J Bensinger,Scott J Dixon

DOI: https://doi.org/10.1016/j.chembiol.2022.06.004

2022-09-15

Abstract:Ferroptosis is an important mediator of pathophysiological cell death and an emerging target for cancer therapy. Whether ferroptosis sensitivity is governed by a single regulatory mechanism is unclear. Here, based on the integration of 24 published chemical genetic screens combined with targeted follow-up experimentation, we find that the genetic regulation of ferroptosis sensitivity is highly variable and context-dependent. For example, the lipid metabolic gene acyl-coenzyme A (CoA) synthetase long chain family member 4 (ACSL4) appears far more essential for ferroptosis triggered by direct inhibition of the lipid hydroperoxidase glutathione peroxidase 4 (GPX4) than by cystine deprivation. Despite this, distinct pro-ferroptotic stimuli converge upon a common lethal effector mechanism: accumulation of lipid peroxides at the plasma membrane. These results indicate that distinct genetic mechanisms regulate ferroptosis sensitivity, with implications for the initiation and analysis of this process in vivo.
Dynamic regulation of ferroptosis by lipid metabolism.

T. Wu,Nathchar Naowarojna,Mengyu Li,Y. Zou,Jingrong Regina Han,Zijian Pan

DOI: https://doi.org/10.1089/ars.2023.0278

2023-03-27

Antioxidants and Redox Signaling

Abstract:SIGNIFICANCE Ferroptosis is featured by the accumulation of polyunsaturated-lipid peroxidation on cellular membranes in an iron-dependent manner. Ferroptosis has been implicated in various pathophysiological processes including cancer, neurodegeneration, and ischemia-reperfusion tissue injury. However, our understanding about the dynamic and context-specific regulation of ferroptosis remains incomplete. RECENT ADVANCES As the major substrate for peroxidation, the cellular lipidome regulates ferroptosis sensitivity and execution by controlling the abundance and availability of polyunsaturated-lipids for peroxidative modifications. In turn, the cellular lipidome is regulated by a complex network of enzymes and transporters, as well as upstream layers of receptors, kinases and transcription factors. A number of research has shed light on the link between lipid metabolism and ferroptosis. Here we summarize our current knowledge on the role of the lipidome and associated protein regulators in various stages of ferroptosis, ranging from initiation, execution to cell death evasion by cells experiencing ferroptotic stress. CRITICAL ISSUES This review provides an overview of the mechanisms underlying lipid peroxidation and ferroptosis by discussing the lipid species that directly contribute to lipid peroxidation and ferroptosis, how cells regulate the abundances of these pro-ferroptosis lipids, how lipid peroxidation causes cell death, and how cells prevent and repair membrane lipid damage under ferroptotic conditions. FUTURE DIRECTIONS Cell fate regulation in vivo could be different from in vitro culture settings. We envision that a comprehensive and detailed understanding about these important questions in the dynamic regulation of ferroptosis in vivo will accelerate our development of ferroptosis-targeted therapies to improve human health.

Chemistry,Medicine,Biology
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Moataz Abdalkader,Riikka Lampinen,Katja M Kanninen,Tarja M Malm,Jeffrey R Liddell

DOI: https://doi.org/10.3389/fnins.2018.00466

2018-07-10

Abstract:Ferroptosis is a newly described form of regulated cell death, distinct from apoptosis, necroptosis and other forms of cell death. Ferroptosis is induced by disruption of glutathione synthesis or inhibition of glutathione peroxidase 4, exacerbated by iron, and prevented by radical scavengers such as ferrostatin-1, liproxstatin-1, and endogenous vitamin E. Ferroptosis terminates with mitochondrial dysfunction and toxic lipid peroxidation. Although conclusive identification of ferroptosis in vivo is challenging, several salient and very well established features of neurodegenerative diseases are consistent with ferroptosis, including lipid peroxidation, mitochondrial disruption and iron dysregulation. Accordingly, interest in the role of ferroptosis in neurodegeneration is escalating and specific evidence is rapidly emerging. One aspect that has thus far received little attention is the antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). This transcription factor regulates hundreds of genes, of which many are either directly or indirectly involved in modulating ferroptosis, including metabolism of glutathione, iron and lipids, and mitochondrial function. This potentially positions Nrf2 as a key deterministic component modulating the onset and outcomes of ferroptotic stress. The minimal direct evidence currently available is consistent with this and indicates that Nrf2 may be critical for protection against ferroptosis. In contrast, abundant evidence demonstrates that enhancing Nrf2 signaling is potently neuroprotective in models of neurodegeneration, although the exact mechanism by which this is achieved is unclear. Further studies are required to determine to extent to which the neuroprotective effects of Nrf2 activation involve the prevention of ferroptosis.
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones

Deguang Liang,Yan Feng,Fereshteh Zandkarimi,Hua Wang,Zeda Zhang,Jinnie Kim,Yanyan Cai,Wei Gu,Xuejun Jiang,Brent R. Stockwell

DOI: https://doi.org/10.1016/j.cell.2023.05.003

2023-06-03

Cell Journal

Abstract:Summary Ferroptosis, a cell death process driven by iron-dependent phospholipid peroxidation, has been implicated in various diseases. There are two major surveillance mechanisms to suppress ferroptosis: one mediated by glutathione peroxidase 4 (GPX4) that catalyzes the reduction of phospholipid peroxides and the other mediated by enzymes, such as FSP1, that produce metabolites with free radical-trapping antioxidant activity. In this study, through a whole-genome CRISPR activation screen, followed by mechanistic investigation, we identified phospholipid-modifying enzymes MBOAT1 and MBOAT2 as ferroptosis suppressors. MBOAT1/2 inhibit ferroptosis by remodeling the cellular phospholipid profile, and strikingly, their ferroptosis surveillance function is independent of GPX4 or FSP1. MBOAT1 and MBOAT2 are transcriptionally upregulated by sex hormone receptors, i.e., estrogen receptor (ER) and androgen receptor (AR), respectively. A combination of ER or AR antagonist with ferroptosis induction significantly inhibited the growth of ER + breast cancer and AR + prostate cancer, even when tumors were resistant to single-agent hormonal therapies. Graphical abstract Download : Download high-res image (216KB) Download : Download full-size image

cell biology
NUPR1 is a critical repressor of ferroptosis

Jiao Liu,Xinxin Song,Feimei Kuang,Qiuhong Zhang,Yangchun Xie,Rui Kang,Guido Kroemer,Daolin Tang

DOI: https://doi.org/10.1038/s41467-021-20904-2

IF: 16.6

2021-01-28

Nature Communications

Abstract:Abstract Ferroptosis is a type of iron-dependent regulated cell death, representing an emerging disease-modulatory mechanism. Transcription factors play multiple roles in ferroptosis, although the key regulator for ferroptosis in iron metabolism remains elusive. Using NanoString technology, we identify NUPR1, a stress-inducible transcription factor, as a driver of ferroptosis resistance. Mechanistically, NUPR1-mediated LCN2 expression blocks ferroptotic cell death through diminishing iron accumulation and subsequent oxidative damage. Consequently, LCN2 depletion mimics NUPR1 deficiency with respect to ferroptosis induction, whereas transfection-enforced re-expression of LCN2 restores resistance to ferroptosis in NUPR1-deficient cells. Pharmacological or genetic blockade of the NUPR1-LCN2 pathway (using NUPR1 shRNA, LCN2 shRNA, pancreas-specific Lcn2 conditional knockout mice , or the small molecule ZZW-115) increases the activity of the ferroptosis inducer erastin and worsens pancreatitis, in suitable mouse models. These findings suggest a link between NUPR1-regulated iron metabolism and ferroptosis susceptibility.

multidisciplinary sciences
Energy metabolism as a regulator of ferroptosis

Yanhong Ma,Fei Han,Junxia Min,Weiqiang Lin

DOI: https://doi.org/10.1080/15384101.2020.1838781

2020-10-28

Cell Cycle

Abstract:Ferroptosis is a newly identified form of cell death that is regulated by many metabolic pathways, including iron, lipid and amino acids. Recent two studies reveal that the mitochondria and energy stress could also mediate ferroptosis. Gao et al. report that mitochondria play an essential role in ferroptosis induced by cysteine deprivation. In addition, Lee et al. show that energy stress depressed ferroptosis partly through activation of AMP-activated protein kinase. These findings provide potential therapeutic strategies for treating ferroptosis-related diseases, such as cancer, tissue injury and neurodegenerative diseases.

cell biology
Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Yuze Hua,Sen Yang,Yalu Zhang,Jiayi Li,Mengyi Wang,Palashate Yeerkenbieke,Quan Liao,Qiaofei Liu

DOI: https://doi.org/10.1186/s13046-023-02925-5

IF: 12.658

2024-01-14

Journal of Experimental & Clinical Cancer Research

Abstract:Ferroptosis, a novel form of cell death triggered by iron-dependent phospholipid peroxidation, presents significant therapeutic potential across diverse cancer types. Central to cellular metabolism, the metabolic pathways associated with ferroptosis are discernible in both cancerous and immune cells. This review begins by delving into the intricate reciprocal regulation of ferroptosis between cancer and immune cells. It subsequently details how factors within the tumor microenvironment (TME) such as nutrient scarcity, hypoxia, and cellular density modulate ferroptosis sensitivity. We conclude by offering a comprehensive examination of distinct immunophenotypes and environmental and metabolic targets geared towards enhancing ferroptosis responsiveness within the TME. In sum, tailoring precise ferroptosis interventions and combination strategies to suit the unique TME of specific cancers may herald improved patient outcomes.

oncology
Ferroptosis is an autophagic cell death process

Minghui Gao,Prashant Monian,Qiuhui Pan,Wei Zhang,Jenny Xiang,Xuejun Jiang

DOI: https://doi.org/10.1038/cr.2016.95

IF: 44.1

2016-08-12

Cell Research

Abstract:Ferroptosis is an iron-dependent form of regulated necrosis. It is implicated in various human diseases, including ischemic organ damage and cancer. Here, we report the crucial role of autophagy, particularly autophagic degradation of cellular iron storage proteins (a process known as ferritinophagy), in ferroptosis. Using RNAi screening coupled with subsequent genetic analysis, we identified multiple autophagy-related genes as positive regulators of ferroptosis. Ferroptosis induction led to autophagy activation and consequent degradation of ferritin and ferritinophagy cargo receptor NCOA4. Consistently, inhibition of ferritinophagy by blockage of autophagy or knockdown of NCOA4 abrogated the accumulation of ferroptosis-associated cellular labile iron and reactive oxygen species, as well as eventual ferroptotic cell death. Therefore, ferroptosis is an autophagic cell death process, and NCOA4-mediated ferritinophagy supports ferroptosis by controlling cellular iron homeostasis.

cell biology
Recent advances in small-molecule fluorescent probes for studying ferroptosis

Ya-Lin Qi,Hai-Rong Wang,Li-Li Chen,Yong-Tao Duan,Sheng-Yu Yang,Hai-Liang Zhu

DOI: https://doi.org/10.1039/d1cs01167g

IF: 46.2

2022-09-03

Chemical Society Reviews

Abstract:Ferroptosis is an iron-dependent, non-apoptotic form of programmed cell death driven by excessive lipid peroxidation (LPO). Mounting evidence suggests that the unique modality of cell death is involved in the development and progression of several diseases including cancer, cardiovascular diseases (CVDs), neurodegenerative disorders, etc. However, the pathogenesis and signalling pathways of ferroptosis are not fully understood, possibly due to the lack of robust tools for the highly selective and sensitive imaging of ferroptosis analytes in complex living systems. Up to now, various small-molecule fluorescent probes have been applied as promising chemosensors for studying ferroptosis through tracking the biomolecules or microenvironment-related parameters in vitro and in vivo . In this review, we comprehensively reviewed the recent development of small-molecule fluorescent probes for studying ferroptosis, with a focus on the analytes, design strategies and bioimaging applications. We also provided new insights to overcome the major challenges in this emerging field.

chemistry, multidisciplinary
Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator

Tian-Liang Ma,Jing-Xian Chen,Peng Zhu,Chao-Bin Zhang,Yong Zhou,Jia-Xi Duan

DOI: https://doi.org/10.1016/j.lfs.2022.120868

IF: 6.78

2022-10-15

Life Sciences

Abstract:Ferroptosis is a kind of iron-dependent regulatory necrosis characterized by the fatal accumulation of iron-dependent lipid peroxides in the plasma membrane and the final oxidative damage of the cell membrane. Morphologically, ferroptosis features high membrane density, decreased or disappeared cristae, rupture of the mitochondrial outer membrane, plasma membrane integrity loss, cytoplasmic swelling, and organelle swelling. Under physiological conditions, ferroptosis occurs through two major pathways, the extrinsic or transporter-dependent pathway and the intrinsic or enzyme-regulated pathway, triggered by a series of small molecules inside and outside the cell. At present, it is assumed that ferroptosis is mainly related to abnormal toxicity of iron, lipid peroxidation, and mitochondrial dysfunction. With more detailed studies, ferroptosis plays potential pathogenic roles in multisystem diseases as a pathological response, and targeted regulation of ferroptosis in treating ferroptosis-related diseases has broad prospects. In conclusion, it is of great clinical significance to further clarify the specific mechanism of ferroptosis and explore new strategies for ferroptosis regulation. The present review emphatically summarizes the latest mechanism of ferroptosis, focusing on the regulation mechanism and clinical application of ferroptosis inducers and inhibitors. We are devoted to providing new ideas for the further study of ferroptosis and the diagnosis and treatment of ferroptosis-related multisystem diseases.

pharmacology & pharmacy,medicine, research & experimental
NMDARs activation regulates endothelial ferroptosis via the PP2A-AMPK-HMGB1 axis

Wei-Min Han,Yi-Xiang Hong,Guo-Sheng Xiao,Rui-Ying Wang,Gang Li

DOI: https://doi.org/10.1038/s41420-023-01794-3

2024-01-18

Cell Death Discovery

Abstract:N-methyl-D-aspartate receptors (NMDARs) are ligand-gated, voltage-dependent channels of the ionotropic glutamate receptor family. The present study explored whether NMDAR activation induced ferroptosis in vascular endothelial cells and its complicated mechanisms in vivo and in vitro. Various detection approaches were used to determine the ferroptosis-related cellular iron content, lipid reactive oxygen species (LOS), siRNA molecules, RNA-sequence, MDA, GSH, and western blotting. The AMPK activator Acadesine (AICAR), HMGB1 inhibitor glycyrrhizin (GLY), PP2A inhibitor LB-100, and NMDAR inhibitor MK801 were used to investigate the involved in vivo and in vitro pathways. The activation of NMDAR with L-glutamic acid (GLU) or NMDA significantly promoted cellular ferroptosis, iron content, MDA, and the PTGS2 expression, while decreasing GPX4 expression and GSH concentration in human umbilical vein endothelial cells (HUVECs), which was reversed by ferroptosis inhibitors Ferrostatin-1(Fer-1), Liproxstatin-1 (Lip-1), or Deferoxamine (DFO). RNA-seq revealed that ferroptosis and SLC7A11 participate in NMDA or GLU-mediated NMDAR activation. The PP2A-AMPK-HMGB1 pathway was majorly associated with NMDAR activation-induced ferroptosis, validated using the PP2A inhibitor LB-100, AMPK activator AICAR, or HMGB1 siRNA. The role of NMDAR in ferroptosis was validated in HUVECs induced with the ferroptosis activator errasin or RSL3 and counteracted by the NMDAR inhibitor MK-801. The in vivo results showed that NMDA- or GLU-induced ferroptosis and LOS production was reversed by MK-801, LB-100, AICAR, MK-801, and GLY, confirming that the PP2A-AMPK-HMGB1 pathway is involved in NMDAR activation-induced vascular endothelium ferroptosis. In conclusion, the present study demonstrated a novel role of NMDAR in endothelial cell injury by regulating ferroptosis via the PP2A-AMPK-HMGB1 pathway.

cell biology
Metabolic regulation of ferroptosis in the tumor microenvironment

Nneka E. Mbah,Costas A. Lyssiotis

DOI: https://doi.org/10.1016/j.jbc.2022.101617

IF: 5.485

2022-03-01

Journal of Biological Chemistry

Abstract:Ferroptosis is an iron-dependent, nonapoptotic form of regulated cell death triggered by impaired redox and antioxidant machinery and propagated by the accumulation of toxic lipid peroxides. A compendium of experimental studies suggests that ferroptosis is tumor-suppressive. Sensitivity or resistance to ferroptosis can be regulated by cell-autonomous and non-cell-autonomous metabolic mechanisms. This includes a role for ferroptosis that extends beyond the tumor cells themselves, mediated by components of the tumor microenvironment, including T cells and other immune cells. Herein, we review the intrinsic and extrinsic factors that promote the sensitivity of cancer cells to ferroptosis and conclude by describing approaches to harness the full utility of ferroptotic agents as therapeutic options for cancer therapy.

biochemistry & molecular biology
The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy

Xin Jiang,Min Yu,Wei-Kai Wang,Li-Yuan Zhu,Xian Wang,Hong-Chuan Jin,Li-Feng Feng

DOI: https://doi.org/10.1038/s41401-024-01336-2

2024-07-17

Abstract:Ferroptosis is an iron-dependent programmed cell death process that involves lipid oxidation via the Fenton reaction to produce lipid peroxides, causing disruption of the lipid bilayer, which is essential for cellular survival. Ferroptosis has been implicated in the occurrence and treatment response of various types of cancer, and targeting ferroptosis has emerged as a promising strategy for cancer therapy. However, cancer cells can escape cellular ferroptosis by activating or remodeling various signaling pathways, including oxidative stress pathways, thereby limiting the efficacy of ferroptosis-activating targeted therapy. The key anti-oxidative transcription factor, nuclear factor E2 related factor 2 (Nrf2 or NFE2L2), plays a dominant role in defense machinery by reprogramming the iron, intermediate, and glutathione peroxidase 4 (GPX4)-related network and the antioxidant system to attenuate ferroptosis. In this review, we summarize the recent advances in the regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy and explore the prospect of combining Nrf2 inhibitors and ferroptosis inducers as a promising cancer treatment strategy.

Navigating ferroptosis via an NADPH sensor

An NADPH sensor that regulates cell ferroptosis

The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis

Targeting Ferroptosis in Breast Cancer

Regulation of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis inhibition

Ferroptosis Regulation by Nutrient Signalling

The role of non-coding RNAs in ferroptosis regulation

FSP1 oxidizes NADPH to suppress ferroptosis

Context-dependent regulation of ferroptosis sensitivity

Dynamic regulation of ferroptosis by lipid metabolism.

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones

NUPR1 is a critical repressor of ferroptosis

Energy metabolism as a regulator of ferroptosis

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Ferroptosis is an autophagic cell death process

Recent advances in small-molecule fluorescent probes for studying ferroptosis

Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator

NMDARs activation regulates endothelial ferroptosis via the PP2A-AMPK-HMGB1 axis

Metabolic regulation of ferroptosis in the tumor microenvironment

The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy